Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.

Yee DS, Narula N, Ramzy I, Boker J, Ahlering TE, Skarecky DW, Ornstein DK.

Arch Pathol Lab Med. 2007 Jun;131(6):902-8.

PMID:
17550317
2.

Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.

Stewart J, Fleshner N, Cole H, Sweet J.

J Clin Pathol. 2007 Jul;60(7):773-80. Epub 2006 Aug 17.

3.
4.

Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.

Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG.

J Urol. 1999 Apr;161(4):1229-32.

PMID:
10081875
5.

Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.

Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfert RL, Young CY, Klee GG, Tindall DJ, Bostwick DG.

Urology. 1997 Jun;49(6):857-62.

PMID:
9187691
6.

Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.

Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK.

Clin Cancer Res. 2002 Jan;8(1):117-23.

9.

Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium.

Richardsen E, Ukkonen T, Bjørnsen T, Mortensen E, Egevad L, Busch C.

Virchows Arch. 2003 Apr;442(4):329-35. Epub 2003 Apr 1.

PMID:
12684767
10.

Expression of prostate stem cell antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.

Barbisan F, Mazzucchelli R, Santinelli A, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R.

Histopathology. 2010 Oct;57(4):572-9. doi: 10.1111/j.1365-2559.2010.03666.x.

PMID:
20955382
12.

Elevated expression of angiogenin in prostate cancer and its precursors.

Katona TM, Neubauer BL, Iversen PW, Zhang S, Baldridge LA, Cheng L.

Clin Cancer Res. 2005 Dec 1;11(23):8358-63.

14.

Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?

Hailemariam S, Vosbeck J, Cathomas G, Zlobec I, Mattarelli G, Eichenberger T, Zellweger T, Bachmann A, Gasser TC, Bubendorf L.

Hum Pathol. 2011 May;42(5):702-9. doi: 10.1016/j.humpath.2010.09.006. Epub 2011 Jan 15.

PMID:
21237492
15.

Prostatic adenocarcinoma with glomeruloid features.

Pacelli A, Lopez-Beltran A, Egan AJ, Bostwick DG.

Hum Pathol. 1998 May;29(5):543-6.

PMID:
9596281
16.

Quantitation of conventional histologic parameters and biologic factors in prostatic needle biopsy are useful to distinguish paramalignant from malignant disease.

Silva LC, Saldiva PH, Ellinger F, Filho BL, Capelozzi VL, Antonangelo L.

Pathol Res Pract. 2004;200(9):599-608.

PMID:
15497772
17.

Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.

Jiang J, Ulbright TM, Zhang S, Eckert GJ, Kao C, Gardner TA, Koch MO, Eble JN, Cheng L.

Cancer. 2002 Jul 15;95(2):296-300.

18.

PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.

Pan CX, Kinch MS, Kiener PA, Langermann S, Serrero G, Sun L, Corvera J, Sweeney CJ, Li L, Zhang S, Baldridge LA, Jones TD, Koch MO, Ulbright TM, Eble JN, Cheng L.

Clin Cancer Res. 2004 Feb 15;10(4):1333-7.

19.

Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.

Jack GS, Brash AR, Olson SJ, Manning S, Coffey CS, Smith JA Jr, Shappell SB.

Hum Pathol. 2000 Sep;31(9):1146-54.

PMID:
11014584
20.

Loss of 14-3-3sigma in prostate cancer and its precursors.

Cheng L, Pan CX, Zhang JT, Zhang S, Kinch MS, Li L, Baldridge LA, Wade C, Hu Z, Koch MO, Ulbright TM, Eble JN.

Clin Cancer Res. 2004 May 1;10(9):3064-8.

Supplemental Content

Support Center